BMY

Biggest Movers in Healthcare Stocks Now – ACT HSP FRX AZN

Healthcare stocks remained flat on Wednesday morning on Wall Street. NYSE:ACT, NYSE:HSP, NYSE:FRX, NYSE:AZN, NYSE:WCG, NYSE:SNY, NYSE:HCA, NASDAQ:ALXN, NASDAQ:CLVS, NYSE:BMY, NASDAQ:AUXL, NASDAQ:ISIS, NASDAQ:ESRX, NASDAQ:IRWD, NYSE:CHE, NASDAQ:ICLR, NASDAQ:IMGN, NYSE:PBYI, NASDAQ:CLDX, NYSE:WX More 

Hottest Healthcare Stocks Now – IRWD CBST INCY NPSP

Healthcare stocks advanced 0.2% on Wall Street on Tuesday morning. NASDAQ:IRWD, NASDAQ:CBST, NASDAQ:INCY, NASDAQ:NPSP, NYSE:MRK, NASDAQ:UTHR, NASDAQ:QCOR, NYSE:AZN, NASDAQ:KERX, NYSE:OPK, NASDAQ:SHPG, NYSE:BSX, NYSE:BMY, NYSE:HCA, NYSE:HLS, NYSE:OMI, NYSE:CYH, NYSE:HAE, NYSE:PBYI, NYSE:PFE More 

3 Pharmaceuticals to Profit on Obamacare

More people enrolling in health insurance, that likely means more prescriptions and ultimately more profits for pharmaceuticals. More 

Why Bristol-Myers Squibb is a Top 25 Dividend Giant (BMY)

Bristol-Myers Squibb has been named as a Top 25 Dividend Giant by ETF Channel, with a staggering $3.09B worth of stock held by ETFs. More 

5 Biotech Stocks Promising Future Rewards

Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model. More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

BMY Pummeled After Earnings, But Bristol-Myers Squibb Stock Still a Buy

Bristol-Myers Squibb stock has a lot going for it, like the company's newfound focus on hepatitis C, oncology and immunotherapy. But BMY still might need time to reflect that potential. More